Patients who received the drug, called navacaprant, showed no more improvement in depressive symptoms than people who ...

Of the 503 stocks in the S&P 500 (some companies have two classes of stocks that are included) fewer than 30% of them, or 148 ...

We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a ...

We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a ...

CRISPR Therapeutics' approved medicine could benefit from government coverage in the U.S. This is a good sign for the biotech ...

Here are four drug and biotech stocks, ARQT, MESO, MNPR and KOD, which have more than doubled in 2024 with room for further growth in 2025.

The biotech reported data from KOASTAL-1, the first of three phase 3 trials of navacaprant ... For now, investors are taking ...

The drug and biotech sector had a turbulent year in 2024 ... KOD carries a Zacks Rank #3 (Hold) at present. The stocks have been mostly witnessing favorable earnings estimate revisions as well.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.0, a high estimate of $86.00, ...

Fortress Biotech Inc (FBIO) stock saw a decline, ending the day at $2.18 which represents a decrease of $-0.18 or -7.63% from the prior close of $2.36. The stock opened at $2.33 and touched a low of ...